cholestyramine resin has been researched along with Atherogenesis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, Y; Imajo, K; Iwaki, M; Kasai, Y; Kessoku, T; Kobayashi, N; Kobayashi, T; Nakajima, A; Nogami, A; Ogawa, Y; Ozaki, A; Saito, S; Tanaka, K; Usuda, H; Wada, K; Yoneda, M | 1 |
| Abdeen, S; Abu-Fanne, R; Bdeir, K; Cines, DB; Heyman, SN; Higazi, AA; Higazi, M; Maraga, E; Masarwy, A | 1 |
| Alderson, P; Lewis, SR; Nicholson, A; Sanders, RD; Smith, AF | 1 |
| Masuda, Y; Nishizawa, T; Yamaguchi, S | 1 |
| Cipollone, F; Faggin, E; Ganassin, L; Grego, F; Mezzetti, A; Pauletto, P; Plebani, M; Puato, M; Rattazzi, M; Zambon, A | 1 |
| GRESHAM, GA; HOWARD, AN; JENNINGS, IW; JONES, D | 1 |
1 review(s) available for cholestyramine resin and Atherogenesis
| Article | Year |
|---|---|
Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
Topics: Adult; Angioplasty; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Cause of Death; Cholestyramine Resin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Perioperative Care; Postoperative Complications; Pyrroles; Randomized Controlled Trials as Topic; Sitosterols; Vascular Surgical Procedures | 2013 |
1 trial(s) available for cholestyramine resin and Atherogenesis
| Article | Year |
|---|---|
Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Cholestyramine Resin; Endarterectomy, Carotid; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Lymphocyte Count; Macrophages; Male; Pyrroles; Sitosterols | 2010 |
4 other study(ies) available for cholestyramine resin and Atherogenesis
| Article | Year |
|---|---|
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.
Topics: Animals; Atherosclerosis; Bile Acids and Salts; Carcinogenesis; Cholestyramine Resin; Disease Models, Animal; Mice; Non-alcoholic Fatty Liver Disease | 2023 |
Opposing effects of HNP1 (α-defensin-1) on plasma cholesterol and atherogenesis.
Topics: alpha-Defensins; Animals; Anticholesteremic Agents; Aorta; Atherosclerosis; Cholesterol; Cholestyramine Resin; Colchicine; Diet, High-Fat; Disease Models, Animal; Female; Humans; Lipid Metabolism; Lipoproteins, LDL; Mice; Mice, Knockout, ApoE; Mice, Transgenic; Neutrophils | 2020 |
Cholesterol-lowering pattern affects the progression of atherosclerosis in apolipoprotein E deficient mice.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Atherosclerosis; Cholesterol, LDL; Cholestyramine Resin; Diet, Western; Male; Mice; Mice, Knockout; Triglycerides | 2016 |
THE EFFECT OF CHOLESTYRAMINE ON PLASMA CHOLESTROL AND ATHEROSCLEROSIS IN RABBITS GIVEN A SEMI-SYNTHETIC DIET OF LOW CHOLESTEROL CONTENT.
Topics: Animals; Arteriosclerosis; Atherosclerosis; Cholesterol; Cholestyramine Resin; Diet; Diet, Atherogenic; Food, Formulated; Ion Exchange Resins; Pathology; Pharmacology; Rabbits; Research | 1965 |